FDA Inspection 1095599 — Mylan Laboratories Limited

Mylan Laboratories Limited — FEI 3010453141

The FDA completed an inspection of Mylan Laboratories Limited on May 24, 2019 in Pithampur, District Dhar. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pithampur, District Dhar (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.